Impact of sofosbuvir and daclastavir on health-related quality of life in patients co-infected with hepatitis C and human immunodeficiency virus

BACKGROUND: We conducted a real-life study of health-related quality of life (HRQoL) transformation before and 12 weeks after sofosbuvir and daclatasvir therapy in HCV/HIV co-infected patients. Factors related to the significant changes of each HRQoL domain/item were also evaluated. METHODS: A prosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Yunihastuti, Evy, Amelia, Fhadilla, Hapsari, Arini Ika, Wicaksana, Bramantya, Natali, Veritea, Widhani, Alvina, Sulaiman, Andri Sanityoso, Karjadi, Teguh Harjono
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152304/
https://www.ncbi.nlm.nih.gov/pubmed/34039353
http://dx.doi.org/10.1186/s12955-021-01777-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152304/
https://www.ncbi.nlm.nih.gov/pubmed/34039353
http://dx.doi.org/10.1186/s12955-021-01777-x

Ejemplares similares